Avoiding Liability and Other Legal Land Mines in the Evolving Genomics Landscape

被引:0
|
作者
Clayton, Ellen Wright [1 ,2 ,3 ]
Tritell, Alex M. [3 ]
Thorogood, Adrian M. [4 ]
机构
[1] Vanderbilt Univ, Dept Pediat, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Ctr Biomed Eth & Soc, Med Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Law, Nashville, TN 37232 USA
[4] Terry Fox Res Inst, Montreal, PQ, Canada
关键词
genomics; liability; duty to warn; data privacy; CLINICAL EXOME; REINTERPRETATION; CHALLENGES; GENETICS; ACCESS; ACMG; CARE;
D O I
10.1146/annurev-genom-100722-021725
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This article reviews evolving legal implications for clinicians and researchers as genomics is used more widely in both the clinic and in translational research, reflecting rapid changes in scientific knowledge as well as the surrounding cultural and political environment. Professionals will face new and changing duties to make or act upon a genetic diagnosis, address direct-to-consumer genetic testing in patient care, consider the health implications of results for patients' family members, and recontact patients when test results change over time. Professional duties in reproductive genetic testing will need to be recalibrated in response to disruptive changes to reproductive rights in the United States. We also review the debate over who controls the flow of genetic information and who is responsible for its protection, considering the globally influential European Union General Data Protection Regulation and the rapidly evolving data privacy law landscape of the United States.
引用
收藏
页码:333 / 346
页数:14
相关论文
共 3 条